Copyright Reports & Markets. All rights reserved.

Global Neuropathy Pain Treatment Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Neuropathy Pain Treatment by Type
    • 1.3.1 Overview: Global Neuropathy Pain Treatment Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Neuropathy Pain Treatment Consumption Value Market Share by Type in 2024
    • 1.3.3 Calcium Channel Alpha 2-delta Ligands
    • 1.3.4 Serotonin-norepinephrine Reuptake Inhibitors
    • 1.3.5 Others
  • 1.4 Global Neuropathy Pain Treatment Market by Application
    • 1.4.1 Overview: Global Neuropathy Pain Treatment Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Retail Pharmacies
    • 1.4.3 Hospitals
    • 1.4.4 Others
  • 1.5 Global Neuropathy Pain Treatment Market Size & Forecast
  • 1.6 Global Neuropathy Pain Treatment Market Size and Forecast by Region
    • 1.6.1 Global Neuropathy Pain Treatment Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Neuropathy Pain Treatment Market Size by Region, (2020-2031)
    • 1.6.3 North America Neuropathy Pain Treatment Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Neuropathy Pain Treatment Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Neuropathy Pain Treatment Market Size and Prospect (2020-2031)
    • 1.6.6 South America Neuropathy Pain Treatment Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Neuropathy Pain Treatment Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Neuropathy Pain Treatment Product and Solutions
    • 2.1.4 Pfizer Neuropathy Pain Treatment Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Pfizer Recent Developments and Future Plans
  • 2.2 Depomed
    • 2.2.1 Depomed Details
    • 2.2.2 Depomed Major Business
    • 2.2.3 Depomed Neuropathy Pain Treatment Product and Solutions
    • 2.2.4 Depomed Neuropathy Pain Treatment Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Depomed Recent Developments and Future Plans
  • 2.3 Eli Lilly
    • 2.3.1 Eli Lilly Details
    • 2.3.2 Eli Lilly Major Business
    • 2.3.3 Eli Lilly Neuropathy Pain Treatment Product and Solutions
    • 2.3.4 Eli Lilly Neuropathy Pain Treatment Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Eli Lilly Recent Developments and Future Plans
  • 2.4 Endo
    • 2.4.1 Endo Details
    • 2.4.2 Endo Major Business
    • 2.4.3 Endo Neuropathy Pain Treatment Product and Solutions
    • 2.4.4 Endo Neuropathy Pain Treatment Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Endo Recent Developments and Future Plans
  • 2.5 Grünenthal Group
    • 2.5.1 Grünenthal Group Details
    • 2.5.2 Grünenthal Group Major Business
    • 2.5.3 Grünenthal Group Neuropathy Pain Treatment Product and Solutions
    • 2.5.4 Grünenthal Group Neuropathy Pain Treatment Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Grünenthal Group Recent Developments and Future Plans
  • 2.6 Arbor Pharmaceuticals
    • 2.6.1 Arbor Pharmaceuticals Details
    • 2.6.2 Arbor Pharmaceuticals Major Business
    • 2.6.3 Arbor Pharmaceuticals Neuropathy Pain Treatment Product and Solutions
    • 2.6.4 Arbor Pharmaceuticals Neuropathy Pain Treatment Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Arbor Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Neuropathy Pain Treatment Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Neuropathy Pain Treatment by Company Revenue
    • 3.2.2 Top 3 Neuropathy Pain Treatment Players Market Share in 2024
    • 3.2.3 Top 6 Neuropathy Pain Treatment Players Market Share in 2024
  • 3.3 Neuropathy Pain Treatment Market: Overall Company Footprint Analysis
    • 3.3.1 Neuropathy Pain Treatment Market: Region Footprint
    • 3.3.2 Neuropathy Pain Treatment Market: Company Product Type Footprint
    • 3.3.3 Neuropathy Pain Treatment Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Neuropathy Pain Treatment Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Neuropathy Pain Treatment Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Neuropathy Pain Treatment Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Neuropathy Pain Treatment Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Neuropathy Pain Treatment Consumption Value by Type (2020-2031)
  • 6.2 North America Neuropathy Pain Treatment Market Size by Application (2020-2031)
  • 6.3 North America Neuropathy Pain Treatment Market Size by Country
    • 6.3.1 North America Neuropathy Pain Treatment Consumption Value by Country (2020-2031)
    • 6.3.2 United States Neuropathy Pain Treatment Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Neuropathy Pain Treatment Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Neuropathy Pain Treatment Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Neuropathy Pain Treatment Consumption Value by Type (2020-2031)
  • 7.2 Europe Neuropathy Pain Treatment Consumption Value by Application (2020-2031)
  • 7.3 Europe Neuropathy Pain Treatment Market Size by Country
    • 7.3.1 Europe Neuropathy Pain Treatment Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Neuropathy Pain Treatment Market Size and Forecast (2020-2031)
    • 7.3.3 France Neuropathy Pain Treatment Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Neuropathy Pain Treatment Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Neuropathy Pain Treatment Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Neuropathy Pain Treatment Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Neuropathy Pain Treatment Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Neuropathy Pain Treatment Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Neuropathy Pain Treatment Market Size by Region
    • 8.3.1 Asia-Pacific Neuropathy Pain Treatment Consumption Value by Region (2020-2031)
    • 8.3.2 China Neuropathy Pain Treatment Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Neuropathy Pain Treatment Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Neuropathy Pain Treatment Market Size and Forecast (2020-2031)
    • 8.3.5 India Neuropathy Pain Treatment Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Neuropathy Pain Treatment Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Neuropathy Pain Treatment Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Neuropathy Pain Treatment Consumption Value by Type (2020-2031)
  • 9.2 South America Neuropathy Pain Treatment Consumption Value by Application (2020-2031)
  • 9.3 South America Neuropathy Pain Treatment Market Size by Country
    • 9.3.1 South America Neuropathy Pain Treatment Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Neuropathy Pain Treatment Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Neuropathy Pain Treatment Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Neuropathy Pain Treatment Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Neuropathy Pain Treatment Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Neuropathy Pain Treatment Market Size by Country
    • 10.3.1 Middle East & Africa Neuropathy Pain Treatment Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Neuropathy Pain Treatment Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Neuropathy Pain Treatment Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Neuropathy Pain Treatment Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Neuropathy Pain Treatment Market Drivers
  • 11.2 Neuropathy Pain Treatment Market Restraints
  • 11.3 Neuropathy Pain Treatment Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Neuropathy Pain Treatment Industry Chain
  • 12.2 Neuropathy Pain Treatment Upstream Analysis
  • 12.3 Neuropathy Pain Treatment Midstream Analysis
  • 12.4 Neuropathy Pain Treatment Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Neuropathy Pain Treatment market size was valued at US$ 9358 million in 2024 and is forecast to a readjusted size of USD 11660 million by 2031 with a CAGR of 3.2% during review period.
    This report studies the Neuropathy Pain Treatment market,
    Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathy Pain Treatment is used for Neuropathic pain.
    Global Neuropathy Pain Treatment key players include Eli Lilly, Pfizer, etc. Global top two manufacturers hold a share over 65%.
    North America is the largest market, with a share about 45%, followed by Asia-Pacific and Europe, both have a share about 50 percent.
    In terms of product, Calcium channel alpha 2-delta ligands is the largest segment, with a share about 70%. And in terms of application, the largest application is Retail Pharmacies, followed by Hospitals, etc.
    This report is a detailed and comprehensive analysis for global Neuropathy Pain Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Neuropathy Pain Treatment market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Neuropathy Pain Treatment market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Neuropathy Pain Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Neuropathy Pain Treatment market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Neuropathy Pain Treatment
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Neuropathy Pain Treatment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Depomed, Eli Lilly, Endo, Grünenthal Group, Arbor Pharmaceuticals, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Neuropathy Pain Treatment market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Calcium Channel Alpha 2-delta Ligands
    Serotonin-norepinephrine Reuptake Inhibitors
    Others
    Market segment by Application
    Retail Pharmacies
    Hospitals
    Others
    Market segment by players, this report covers
    Pfizer
    Depomed
    Eli Lilly
    Endo
    Grünenthal Group
    Arbor Pharmaceuticals
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Neuropathy Pain Treatment product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Neuropathy Pain Treatment, with revenue, gross margin, and global market share of Neuropathy Pain Treatment from 2020 to 2025.
    Chapter 3, the Neuropathy Pain Treatment competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Neuropathy Pain Treatment market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Neuropathy Pain Treatment.
    Chapter 13, to describe Neuropathy Pain Treatment research findings and conclusion.

    Buy now